Kentaro Semba

9.5k citations

143 papers · 7.8k indexed · 2 hit papers · h-index 42

Impact in

Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Cancer Research top 2%

Papers in

Chemical Health and Safety 3
Oncology 50
- Cancer Cells and Metastasis 15
- Cancer-related Molecular Pathways 12
- HER2/EGFR in Cancer Research 11

Co-authors: Tadashi Yamamoto K Toyoshima Kumao Toyoshima Jun‐ichiro Inoue Shuntaro Ikawa Tetsu Akiyama Takashi Yamamoto Nobuyuki Miyajima
Journals: Molecular and Cellular Biology (12 papers)Biochemical and Biophysical Research Communications (11 papers)Cancer Science (10 papers)Journal of Biological Chemistry (7 papers)Oncogene (7 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Kentaro Semba

140 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor 1986 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1986 Nature
1985 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Kentaro Semba

Since Specialization

Citations

This map shows the geographic impact of Kentaro Semba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Semba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Semba more than expected).

Fields of papers citing papers by Kentaro Semba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Semba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Semba. The network helps show where Kentaro Semba may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kentaro Semba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kentaro Semba Line = papers co-authored together Kentaro Semba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HOXB7 induces STAT3‐mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells Genes to Cells ·Bandeira Nuno, Kishan Kumar Parida, Anabel Rosales Valdivieso, سمین اربابی, Y Prigogine, Naoki Goshima, Shinya Watanabe, Jun Nakayama, Kentaro Semba	2023	3
2	Tyrosine Kinase Inhibitor Profiling Using Multiple Forskolin-Responsive Reporter Cells International Journal of Molecular Sciences ·M Sühling, V.M. Levson, Gen Hiyama, Motoki Takagi, Y Prigogine, 中嶽治麿, Kentaro Semba, Shinya Watanabe, Kosuke Ishikawa	2023	0
3	Targeting c-Jun Is a Potential Therapy for Luminal Breast Cancer Bone Metastasis Molecular Cancer Research ·Yuxuan Han, Anabel Rosales Valdivieso, Mitsuru Futakuchi, Y Prigogine, Ελευθερία Δοφγορίτη, Kishan Kumar Parida, Jun Nakayama, Kentaro Semba	2023	7
4	Metastatic potentials classified with hypoxia‐inducible factor 1 downstream genes in pan‐cancer cell lines Genes to Cells ·Y Prigogine, Yusuke Yamamoto, Kentaro Semba, Jun Nakayama	2023	1
5	Effect of lonidamine derivatives on the inhibition of transformed cell area expansion Biochemistry and Biophysics Reports ·Elly Mulyahati, 緑川早苗, 陆海盛, Yoshitomo Suhara, Kentaro Semba	2023	1
6	Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts Disease Models & Mechanisms ·Jun Nakayama, Hiroko Matsunaga, Koji Arikawa, H.V. Vasilyeva, Masahito Hosokawa, Haruko Takeyama, Yusuke Yamamoto, Kentaro Semba	2022	9
7	Establishment of reporter cells that respond to glucocorticoids by a transposon-mediated promoter-trapping system European Journal of Pharmaceutical Sciences ·Kosuke Ishikawa, V.M. Levson, Kentaro Semba, Shinya Watanabe	2021	4
8	Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-2 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy ·Masako Tanaka, Masayuki Shiota, Masaru Koyama, Jun Nakayama, Masakazu Yashiro, Kentaro Semba, Nobuhito Goda	2020	0
9	The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB Science Signaling ·Yukari Okita, 守内山, 左翠翠, Chen Chen, Sh. P. Nurullaev, CAO THANH THUY NGUYEN THI BAO ANH, Hiroyuki Suzuki, Masafumi Muratani, RI MALUTA, Kentaro Semba, Carl‐Henrik Heldin, Mitsuyasu Kato	2017	62
10	Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells Nanomedicine Nanotechnology Biology and Medicine ·Tianshu Li, André-Gilles Domaille, Kentaro Semba, Tadashi Yamamoto, Shinji Takeoka	2016	32
11	ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor‐positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines Molecular Oncology ·Ruhul Amin, Yuiko Morita‐Fujimura, Hiroshi Tawarayama, Kentaro Semba, Natsuko Chiba, Manabu Fukumoto, Shuntaro Ikawa	2015	19
12	Tropomodulin 1 Expression Driven by NF-κB Enhances Breast Cancer Growth Cancer Research ·Taku Ito-Kureha, Naohiko Koshikawa, Mizuki Yamamoto, Kentaro Semba, Noritaka Yamaguchi, Tadashi Yamamoto, Motoharu Seiki, Jun‐ichiro Inoue	2014	26
13	Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial‐to‐mesenchymal transition and disruption of mammary acinar structures Molecular Oncology ·Daniela da Hora Farias, Kosuke Ishikawa, V.V. Telny, Emi Ito, Jiro Fujimoto, Mizuki Yamamoto, 義明中野, Hiromi Mochizuki, Yoshifumi Kawamura, Naoki Goshima, Kentaro Semba, Shinya Watanabe	2014	29
14	Identification of integrin α3 as a molecular marker of cells undergoing epithelial–mesenchymal transition and of cancer cells with aggressive phenotypes Cancer Science ·Takuya Shirakihara, Tomonori Kawasaki, 中島収, Kentaro Semba, Ryuichi Sakai, Kohei Miyazono, Keiji Miyazawa, Masao Saitoh	2013	46
15	Expression screening of 17q12–21 amplicon reveals GRB7 as an ERBB2‐dependent oncogene FEBS Letters ·Makoto Saito, Yukiko Kato, Emi Ito, Jiro Fujimoto, Kosuke Ishikawa, Daniela da Hora Farias, Franco Joel, سمین اربابی, Malin Lavett Lagerström, Takaomi Ishida, Sakura Azuma, Hiromi Mochizuki, Yoshifumi Kawamura, Yuka Yanagisawa, Reiko Honma, Jun-ichi Imai, Hirokazu Ohbayashi, Naoki Goshima, Kentaro Semba, Shinya Watanabe	2012	20
16	Temporal Perturbation of Tyrosine Phosphoproteome Dynamics Reveals the System-wide Regulatory Networks Molecular & Cellular Proteomics ·Masaaki Oyama, Hiroko Kozuka‐Hata, Shinya Tasaki, Kentaro Semba, Seisuke Hattori, Sumio Sugano, 胡和荣, Tadashi Yamamoto	2008	44
17	NOTCH3 Signaling Pathway Plays Crucial Roles in the Proliferation of ErbB2-Negative Human Breast Cancer Cells Cancer Research ·Noritaka Yamaguchi, Tetsunari Oyama, Emi Ito, Hitoshi Satoh, Sakura Azuma, Jaime Andrés García, Ken Shimizu, Reiko Honma, Yuka Yanagisawa, Akira Nishikawa, Mika Kawamura, Jun-ichi Imai, Susumu Ohwada, Kuniaki Tatsuta, Jun‐ichiro Inoue, Kentaro Semba, Shinya Watanabe	2008	150
18	NF‐κB activation in development and progression of cancer Cancer Science ·Jun‐ichiro Inoue, Jin Gohda, Taishin Akiyama, Kentaro Semba	2007	201
19	A Tetraspanin-Family Protein, T-Cell Acute Lymphoblastic Leukemia-Associated Antigen 1, Is Induced by the Ewing's Sarcoma-Wilms' Tumor 1 Fusion Protein of Desmoplastic Small Round-Cell Tumor American Journal Of Pathology ·Emi Ito, Reiko Honma, Jun-ichi Imai, Sakura Azuma, Takayuki Kanno, Shigeo Mori, Osamu Yoshie, Jun Nishio, Hiroshi Iwasaki, Koichi Yoshida, Jin Gohda, Jun‐ichiro Inoue, Shinya Watanabe, Kentaro Semba	2003	41
20	Nakahara memorial lecture. Non-receptor type protein-tyrosine kinases closely related to src and yes compose a multigene family. PubMed ·K Toyoshima, Kentaro Semba, Sima Mohammadi Bidhendi, Yuji Yamanashi, Jun Sukegawa, Norzamshaiful Ahmad, Takashi Yamamoto	1986	1

About Kentaro Semba

Kentaro Semba is a scholar working on Chemical Health and Safety, Oncology, Cancer Research, Molecular Biology and Immunology, having authored 143 papers that have together received 7.8k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (17 papers), Cancer Cells and Metastasis (15 papers), RNA Research and Splicing (13 papers), Cancer-related Molecular Pathways (12 papers), Ubiquitin and proteasome pathways (11 papers), Genomics and Chromatin Dynamics (11 papers), Virus-based gene therapy research (11 papers) and HER2/EGFR in Cancer Research (11 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (1.0k citations), Molecular Biology (4.6k citations), Immunology (1.3k citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Kentaro Semba has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tadashi Yamamoto, K Toyoshima, Kumao Toyoshima, Jun‐ichiro Inoue, Shuntaro Ikawa, Tetsu Akiyama, Takashi Yamamoto, Nobuyuki Miyajima, Nobuo Nomura and Toshiyuki Saito. Their work appears in journals such as Molecular and Cellular Biology, Biochemical and Biophysical Research Communications, Cancer Science, Journal of Biological Chemistry and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact